Cargando…

SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June–October 2020

OBJECTIVES: It has been suggested that ethnic minorities have been disproportionally affected by the COVID-19. We aimed to determine whether prevalence and correlates of past SARS-CoV-2 exposure varied between six ethnic groups in Amsterdam, the Netherlands. DESIGN, SETTING, PARTICIPANTS: Participan...

Descripción completa

Detalles Bibliográficos
Autores principales: Coyer, Liza, Boyd, Anders, Schinkel, Janke, Agyemang, Charles, Galenkamp, Henrike, Koopman, Anitra D M, Leenstra, Tjalling, Moll van Charante, Eric P, van den Born, Bert-Jan H, Lok, Anja, Verhoeff, Arnoud, Zwinderman, Aeilko H, Jurriaans, Suzanne, van Vught, Lonneke A, Stronks, Karien, Prins, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739540/
https://www.ncbi.nlm.nih.gov/pubmed/34992110
http://dx.doi.org/10.1136/bmjopen-2021-052752
_version_ 1784629122782199808
author Coyer, Liza
Boyd, Anders
Schinkel, Janke
Agyemang, Charles
Galenkamp, Henrike
Koopman, Anitra D M
Leenstra, Tjalling
Moll van Charante, Eric P
van den Born, Bert-Jan H
Lok, Anja
Verhoeff, Arnoud
Zwinderman, Aeilko H
Jurriaans, Suzanne
van Vught, Lonneke A
Stronks, Karien
Prins, Maria
author_facet Coyer, Liza
Boyd, Anders
Schinkel, Janke
Agyemang, Charles
Galenkamp, Henrike
Koopman, Anitra D M
Leenstra, Tjalling
Moll van Charante, Eric P
van den Born, Bert-Jan H
Lok, Anja
Verhoeff, Arnoud
Zwinderman, Aeilko H
Jurriaans, Suzanne
van Vught, Lonneke A
Stronks, Karien
Prins, Maria
author_sort Coyer, Liza
collection PubMed
description OBJECTIVES: It has been suggested that ethnic minorities have been disproportionally affected by the COVID-19. We aimed to determine whether prevalence and correlates of past SARS-CoV-2 exposure varied between six ethnic groups in Amsterdam, the Netherlands. DESIGN, SETTING, PARTICIPANTS: Participants aged 25–79 years enrolled in the Healthy Life in an Urban Setting population-based prospective cohort (n=16 889) were randomly selected within ethnic groups and invited to participate in a cross-sectional COVID-19 seroprevalence substudy. OUTCOME MEASURES: We tested participants for SARS-CoV-2-specific antibodies and collected information on SARS-CoV-2 exposures. We estimated prevalence and correlates of SARS-CoV-2 exposure within ethnic groups using survey-weighted logistic regression adjusting for age, sex and calendar time. RESULTS: Between 24 June and 9 October 2020, we included 2497 participants. Adjusted SARS-CoV-2 seroprevalence was comparable between ethnic Dutch (24/498; 5.1%, 95% CI 2.8% to 7.4%), South-Asian Surinamese (22/451; 4.9%, 95% CI 2.2% to 7.7%), African Surinamese (22/400; 8.3%, 95% CI 3.1% to 13.6%), Turkish (30/408; 7.9%, 95% CI 4.4% to 11.4%) and Moroccan (32/391; 7.2%, 95% CI 4.2% to 10.1%) participants, but higher among Ghanaians (95/327; 26.3%, 95% CI 18.5% to 34.0%). 57.1% of SARS-CoV-2-positive participants did not suspect or were unsure of being infected, which was lowest in African Surinamese (18.2%) and highest in Ghanaians (90.5%). Correlates of SARS-CoV-2 exposure varied across ethnic groups, while the most common correlate was having a household member suspected of infection. In Ghanaians, seropositivity was associated with older age, larger household sizes, living with small children, leaving home to work and attending religious services. CONCLUSIONS: No remarkable differences in SARS-CoV-2 seroprevalence were observed between the largest ethnic groups in Amsterdam after the first wave of infections. The higher infection seroprevalence observed among Ghanaians, which passed mostly unnoticed, warrants wider prevention efforts and opportunities for non-symptom-based testing.
format Online
Article
Text
id pubmed-8739540
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-87395402022-01-07 SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June–October 2020 Coyer, Liza Boyd, Anders Schinkel, Janke Agyemang, Charles Galenkamp, Henrike Koopman, Anitra D M Leenstra, Tjalling Moll van Charante, Eric P van den Born, Bert-Jan H Lok, Anja Verhoeff, Arnoud Zwinderman, Aeilko H Jurriaans, Suzanne van Vught, Lonneke A Stronks, Karien Prins, Maria BMJ Open Infectious Diseases OBJECTIVES: It has been suggested that ethnic minorities have been disproportionally affected by the COVID-19. We aimed to determine whether prevalence and correlates of past SARS-CoV-2 exposure varied between six ethnic groups in Amsterdam, the Netherlands. DESIGN, SETTING, PARTICIPANTS: Participants aged 25–79 years enrolled in the Healthy Life in an Urban Setting population-based prospective cohort (n=16 889) were randomly selected within ethnic groups and invited to participate in a cross-sectional COVID-19 seroprevalence substudy. OUTCOME MEASURES: We tested participants for SARS-CoV-2-specific antibodies and collected information on SARS-CoV-2 exposures. We estimated prevalence and correlates of SARS-CoV-2 exposure within ethnic groups using survey-weighted logistic regression adjusting for age, sex and calendar time. RESULTS: Between 24 June and 9 October 2020, we included 2497 participants. Adjusted SARS-CoV-2 seroprevalence was comparable between ethnic Dutch (24/498; 5.1%, 95% CI 2.8% to 7.4%), South-Asian Surinamese (22/451; 4.9%, 95% CI 2.2% to 7.7%), African Surinamese (22/400; 8.3%, 95% CI 3.1% to 13.6%), Turkish (30/408; 7.9%, 95% CI 4.4% to 11.4%) and Moroccan (32/391; 7.2%, 95% CI 4.2% to 10.1%) participants, but higher among Ghanaians (95/327; 26.3%, 95% CI 18.5% to 34.0%). 57.1% of SARS-CoV-2-positive participants did not suspect or were unsure of being infected, which was lowest in African Surinamese (18.2%) and highest in Ghanaians (90.5%). Correlates of SARS-CoV-2 exposure varied across ethnic groups, while the most common correlate was having a household member suspected of infection. In Ghanaians, seropositivity was associated with older age, larger household sizes, living with small children, leaving home to work and attending religious services. CONCLUSIONS: No remarkable differences in SARS-CoV-2 seroprevalence were observed between the largest ethnic groups in Amsterdam after the first wave of infections. The higher infection seroprevalence observed among Ghanaians, which passed mostly unnoticed, warrants wider prevention efforts and opportunities for non-symptom-based testing. BMJ Publishing Group 2022-01-06 /pmc/articles/PMC8739540/ /pubmed/34992110 http://dx.doi.org/10.1136/bmjopen-2021-052752 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Infectious Diseases
Coyer, Liza
Boyd, Anders
Schinkel, Janke
Agyemang, Charles
Galenkamp, Henrike
Koopman, Anitra D M
Leenstra, Tjalling
Moll van Charante, Eric P
van den Born, Bert-Jan H
Lok, Anja
Verhoeff, Arnoud
Zwinderman, Aeilko H
Jurriaans, Suzanne
van Vught, Lonneke A
Stronks, Karien
Prins, Maria
SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June–October 2020
title SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June–October 2020
title_full SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June–October 2020
title_fullStr SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June–October 2020
title_full_unstemmed SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June–October 2020
title_short SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June–October 2020
title_sort sars-cov-2 antibody prevalence and correlates of six ethnic groups living in amsterdam, the netherlands: a population-based cross-sectional study, june–october 2020
topic Infectious Diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739540/
https://www.ncbi.nlm.nih.gov/pubmed/34992110
http://dx.doi.org/10.1136/bmjopen-2021-052752
work_keys_str_mv AT coyerliza sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020
AT boydanders sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020
AT schinkeljanke sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020
AT agyemangcharles sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020
AT galenkamphenrike sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020
AT koopmananitradm sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020
AT leenstratjalling sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020
AT mollvancharanteericp sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020
AT vandenbornbertjanh sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020
AT lokanja sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020
AT verhoeffarnoud sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020
AT zwindermanaeilkoh sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020
AT jurriaanssuzanne sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020
AT vanvughtlonnekea sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020
AT stronkskarien sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020
AT prinsmaria sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020